Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 2/20 | 0.50 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.43 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.41 |
| ▸ | ESR1 | P03372 | 1/20 | 0.41 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.41 |
| ▸ | GAA | P10253 | 2/20 | 0.34 |
| ▸ | MEN1 | O00255 | 1/20 | 0.34 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.32 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13110304 | 0.83 | TSHR (0.50) | TSHRKMT2AALDH1A1ESR1HSD17B10 | |
| SCHEMBL28364620 | 0.80 | KMT2A (0.40) | TSHRKMT2AALDH1A1ESR1HSD17B10 | |
| SCHEMBL1138567 | 0.80 | KMT2A (0.63) | TSHRKMT2AALDH1A1ESR1HSD17B10 | |
| SCHEMBL4325339 | 0.80 | TSHR (0.55) | TSHRKMT2AALDH1A1ESR1HSD17B10 | |
| SCHEMBL987544 | 0.80 | TSHR (0.55) | TSHRKMT2AALDH1A1ESR1HSD17B10 | |
| SCHEMBL13008698 | 0.80 | TSHR (0.35) | TSHRKMT2AALDH1A1ESR1HSD17B10 | |
| SCHEMBL16341866 | 0.80 | TSHR (0.48) | TSHRKMT2AALDH1A1ESR1HSD17B10 | |
| SCHEMBL12921994 | 0.79 | TSHR (0.61) | TSHRKMT2AALDH1A1ESR1HSD17B10 | |
| SCHEMBL8503955 | 0.77 | KMT2A (0.44) | TSHRKMT2AALDH1A1ESR1HSD17B10 | |
| SCHEMBL1138474 | 0.77 | TSHR (0.46) | TSHRKMT2AALDH1A1ESR1HSD17B10 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 25 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-1649566-B | Stabilized body care products, household products, textiles and fabrics | CIBA SC HOLDING AG | 2010-05-26 | — | — | CN | claimed |
| CN-1649566-A | Stabilized body care products, household products, textiles and fabrics | CIBA SC HOLDING AG (CH) | 2005-08-03 | — | — | CN | claimed |
| US-5096950-A | N-alkoxypiperidines | CIBA-GEIGY CORPORATION (US) | 1992-03-17 | — | — | US | claimed |
| EP-0365481-A1 | Polymeric substrates stabilized with N-substituted hindered amines | CIBA-GEIGY AG (CH) | 1990-04-25 | — | — | EP | claimed |
| CN-103502528-A | Method of dyeing polyester | HUNTSMAN ADV MAT SWITZERLAND | 2014-01-08 | — | — | CN | disclosed |
| US-8471031-B2 | Process for the preparation of sterically hindered nitroxyl ethers | BASF SE (DE) | 2013-06-25 | — | — | US | disclosed |
| US-8471031-B2 | Process for the preparation of sterically hindered nitroxyl ethers | BASF SE (DE) | 2013-06-25 | — | — | US | disclosed |
| EP-2253667-A1 | POLYLACTIC ACID RESIN COMPOSITION | Adeka Corporation (JP) | 2010-11-24 | — | — | EP | disclosed |
| US-20100249401-A1 | Process for the preparation of sterically hindered nitroxyl ethers | BASF SE (DE) | 2010-09-30 | — | — | US | disclosed |
| US-20100249401-A1 | Process for the preparation of sterically hindered nitroxyl ethers | BASF SE (DE) | 2010-09-30 | — | — | US | disclosed |
| US-7358365-B2 | Process for the controlled increase in the molecular weight of polyethylenes | CIBA SPECIALTY CHEMICALS CORPORATION (US) | 2008-04-15 | — | — | US | disclosed |
| US-6500303-B1 | DERIVATIVES OF 1-OXYL-2,2,6,6-TETRAMETHYL-PIPERIDIN-4-OL; PROTECTION FROM ULTRAVIOLET, FLUORESCENT AND SUN LIGHT EXPOSURE | CIBA SPECIALTY CHEMICALS CORPORATION | 2002-12-31 | — | — | US | disclosed |
| US-5300647-A | Light stabilizers for polyolefins, other polymers | CIBA-GEIGY CORPORATION (US) | 1994-04-05 | — | — | US | disclosed |
| EP-0309400-B1 | N-acyloxy hindered amine stabilizers | CIBA GEIGY AG (CH) | 1994-03-02 | — | — | EP | disclosed |
| US-5124378-A | Resin containign N-Hydroxyl hindered amine oxidative and light stabilizers | CIBA-GEIGY CORPORATION (US) | 1992-06-23 | — | — | US | disclosed |
| US-5112890-A | Piperidine compound with oxygen bonded to ring nitrogen | CIBA-GEIGY CORPORATION (US) | 1992-05-12 | — | — | US | disclosed |
| US-5096950-A | N-alkoxypiperidines | CIBA-GEIGY CORPORATION (US) | 1992-03-17 | — | — | US | disclosed |
| US-5004770-A | Light, heat, and oxygen resistant | CIBA-GEIGY CORPORATION (US) | 1991-04-02 | — | — | US | disclosed |
| EP-0365481-A1 | Polymeric substrates stabilized with N-substituted hindered amines | CIBA-GEIGY AG (CH) | 1990-04-25 | — | — | EP | disclosed |
| EP-0309400-A2 | N-acyloxy hindered amine stabilizers | CIBA-GEIGY AG (CH) | 1989-03-29 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100249401-A1 | Process for the preparation of sterically hindered nitroxyl ethers | PPOX, CBR1, CBR3 | TSHR 3332/4885KMT2A 2110/4885ALDH1A1 889/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.